Large-scale testing (Phase 3)Looking for participantsNCT04513639
What this trial is testing
The Relapse from MRD Negativity As Indication for Treatment (REMNANT) Study
Who this might be right for
Multiple Myeloma
Oslo University Hospital 176
Showing 20 of 0 results